Robert Kalb, MD
Orthopaedic Surgery · Bucyrus, OHNPI 1659377497
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Stryker at 28.4% of the total. Reporting peaked in 2020 at $5,153 and has fallen 50.0% since, to $2,575 in 2025.
Across 90 payments — averaging $193.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- CDC Medical LLC$3K
- Anika Therapeutics, Inc.$2K
- Moximed, Inc$1K
- Wenzel Spine, Inc.$1K
- Vericel Corporation$1K
- plus $4K from 28 others
Across 2 payments — averaging $2617.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$5K
What the payments were for
- Consulting fees$6,46937%
- Travel & lodging$4,04223%
- Food & beverage$4,34225%
- Education$2,59615%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 7 | $4,954 |
| CDC Medical LLC | 3 | $2,596 |
| Anika Therapeutics, Inc. | 4 | $1,873 |
| Moximed, Inc | 3 | $1,402 |
| Wenzel Spine, Inc. | 2 | $1,377 |
| Vericel Corporation | 4 | $1,117 |
| Amgen(2 entities) | 25 | $988 |
| Amniox Medical, Inc. | 1 | $469 |
| 7d Surgical Inc. | 1 | $310 |
| Biotissue Holdings Inc. | 1 | $292 |
| Johnson & Johnson(2 entities) | 3 | $248 |
| Fidia Pharma USA Inc. | 2 | $202 |
| Zimmer Biomet | 2 | $180 |
| Medacta USA, Inc. | 2 | $171 |
| Novo Nordisk | 2 | $159 |
| Conformis, Inc. | 2 | $133 |
| US Implant Solutions, LLC | 1 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. | 1 | $99 |
| Medtronic | 1 | $96 |
| E.r. Squibb & Sons, L.L.C. | 1 | $70 |
| Smith+Nephew | 3 | $68 |
| Heron Therapeutics, Inc. | 2 | $53 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| Orthofix Medical, Inc. | 3 | $35 |
| Acell, Inc. | 2 | $30 |
| Pacira Therapeutics, Inc. | 1 | $30 |
| KCI USA, Inc. | 1 | $28 |
| Globus Medical | 1 | $20 |
| Mimedx Group, Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Acumed LLC | 1 | $15 |
| Radius Health, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIA$4,750
- AERO$4,750
- SERRATO$4,750
- TRITANIUM$4,750
- ARIA$4,750
- MISHA KNEE SYSTEM, SMALL, LEFT$1,388
- Varilift$1,377
- OVOMotion$1,284
- MACI$1,019
- HemiCAP$548
- NEOX$469
- CLARIX$469
- Prokera$292
- AmnioGraft$292
- AmnioGuard$292
- EVENITY$247
- XARELTO$231
- Hymovis$190
- TRILURON$190
- Hip, Identity$121
How this compares
$17,449 in reported general payments places this provider in the 80th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 29 | $1,780 |
| Alendronate Sodium | 59 | $334 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bucyrus
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.